(Q77348001)

English

A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate

scientific article published on 01 September 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753020%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753020%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

author name string

D N Gilbert

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753020%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

B L Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753020%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

R J Dworkin

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753020%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

J L Leggett

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753020%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

H F Chambers

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753020%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

G Modin

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753020%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

M G Täuber

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753020%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

M A Sande

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753020%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 September 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753020%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

American Journal of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753020%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

105

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753020%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753020%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

182-191

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753020%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Once-daily aminoglycoside therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Meta-analyses are no longer required for determining the efficacy of single daily dosing of aminoglycosides

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Comparative trial of single-dose versus twice-daily sisomicin in bacteriuric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

A multicentric study of netilmicin once daily versus thrice daily in patients with appendicitis and other intra-abdominal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Netilmicin in the treatment of gram-negative bacteremia: single daily versus multiple daily dosage

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Prospective randomized study of once-daily versus thrice-daily netilmicin regimens in patients with intraabdominal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic gram-negative infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

A prospective randomized study comparing once- versus twice-daily amikacin dosing in critically ill adult and paediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Pharmacodynamic parameters and toxicity of netilmicin (6 milligrams/kilogram/day) given once daily or in three divided doses to cancer patients with urinary tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Comparison of 5 milligrams of netilmicin per kilogram of body weight once daily versus 2 milligrams per kilogram thrice daily for treatment of gram-negative pyelonephritis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Once- versus twice-daily amikacin regimen: efficacy and safety in systemic gram-negative infections. Scandinavian Amikacin Once Daily Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Once daily administration of netilmicin compared with thrice daily, both in combination with metronidazole, in gangrenous and perforated appendicitis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Once versus thrice daily gentamicin in patients with serious infections

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Intravenous administration of gentamicin once daily versus thrice daily in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Safety, pharmacokinetics and efficacy of once-a-day netilmicin and amikacin versus their conventional schedules in patients suffering from pelvic inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

A study of amikacin given once versus twice daily in serious infections

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Nephrotoxicity, high frequency ototoxicity, efficacy and serum kinetics of once versus thrice daily dosing of netilmicin in patients with serious infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Gentamicin once-daily versus thrice-daily in children

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

A controlled investigation of the pharmacokinetics of gentamicin and tobramycin in obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Experience with a once-daily aminoglycoside program administered to 2,184 adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Once-daily dosing of aminoglycosides: review and recommendations for clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

APACHE II: a severity of disease classification system

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Empiric Therapy for Cancer Patients: Comparative Study of Ticarcillin-Tobramycin, Ticarcillin-Cephalothin, and Cephalothin-Tobramycin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Single or multiple daily doses of aminoglycosides: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Aminoglycosides: single or multiple daily dosing? A meta-analysis on efficacy and safety.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Effectiveness and safety of once-daily aminoglycosides: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900244-7

7 January 2021

Identifiers

10.1016/S0002-9343(98)00244-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753020%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9753020%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77348001&oldid=1746054966"